Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sleep Apnea01:21

Sleep Apnea

242
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
242

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sleep EEG as a Window into Future Brain Health.

Sleep·2026
Same author

Brain atrophy and clinical diagnosis independently predict default mode network failure across the Alzheimer's disease continuum.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026
Same author

Quetiapine modestly improves sleep and breathing but impairs next day performance in people with OSA and difficulty maintaining sleep: A randomized controlled trial.

Annals of the American Thoracic Society·2026
Same author

ACCESS-OSA: a randomized controlled trial for accurate, accessible, and cost-effective screening solutions for obstructive sleep apnoea: study protocol.

Sleep advances : a journal of the Sleep Research Society·2026
Same author

High night-to-night variability in obstructive sleep apnea severity is associated with prevalent cardiovascular disease.

Sleep·2026
Same author

Conservation of NLRP3 Inflammasome Pathway in Monotremes and Large-Scale Restructuring of the Caspase-1 Gene Cluster Region in Mammals.

Journal of molecular evolution·2026

Related Experiment Video

Updated: Oct 20, 2025

Analysis of Brain Mitochondria Using Serial Block-Face Scanning Electron Microscopy
07:47

Analysis of Brain Mitochondria Using Serial Block-Face Scanning Electron Microscopy

Published on: July 9, 2016

14.2K

Brain mitochondrial dysfunction and driving simulator performance in untreated obstructive sleep apnea.

Andrew Vakulin1,2, Michael A Green3,4, Angela L D'Rozario2,5

  • 1Adelaide Institute for Sleep Health/FHMRI Sleep Health, College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.

Journal of Sleep Research
|September 16, 2021
PubMed
Summary

Obstructive sleep apnea (OSA) patients vulnerable to driving impairment show lower brain metabolite levels in frontal regions. This suggests impaired brain energy metabolism may identify OSA patients at risk for driving difficulties.

Keywords:
MRSOSAaccident riskdriving impairmentextended wakefulnessspectroscopy

More Related Videos

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

1.8K
Author Spotlight: Unveiling Mitochondrial Function and Cellular Metabolic Adaptation in Metabolic Diseases
08:12

Author Spotlight: Unveiling Mitochondrial Function and Cellular Metabolic Adaptation in Metabolic Diseases

Published on: October 4, 2024

2.0K

Related Experiment Videos

Last Updated: Oct 20, 2025

Analysis of Brain Mitochondria Using Serial Block-Face Scanning Electron Microscopy
07:47

Analysis of Brain Mitochondria Using Serial Block-Face Scanning Electron Microscopy

Published on: July 9, 2016

14.2K
Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

1.8K
Author Spotlight: Unveiling Mitochondrial Function and Cellular Metabolic Adaptation in Metabolic Diseases
08:12

Author Spotlight: Unveiling Mitochondrial Function and Cellular Metabolic Adaptation in Metabolic Diseases

Published on: October 4, 2024

2.0K

Area of Science:

  • Neuroscience
  • Metabolic research
  • Sleep medicine

Background:

  • Obstructive sleep apnea (OSA) poses challenges in identifying patients with impaired driving ability.
  • Neurobehavioral impairment in OSA may be linked to reduced brain metabolite levels crucial for mitochondrial function.

Purpose of the Study:

  • To compare brain energy metabolism markers in OSA patients vulnerable versus resistant to driving impairment after prolonged wakefulness.
  • To investigate the relationship between specific brain metabolites and driving performance in OSA.

Main Methods:

  • 44 moderate-to-severe OSA patients underwent 28 hours of extended wakefulness with driving simulations.
  • Patients were categorized as vulnerable or resistant to driving impairment using cluster analysis of driving data.
  • 1H magnetic resonance spectroscopy (MRS) measured key metabolites (creatine, glutamate, NAA) in the hippocampus, anterior cingulate cortex, and left orbito-frontal cortex.

Main Results:

  • Vulnerable OSA patients exhibited poorer driving performance compared to resistant individuals.
  • Lower levels of creatine, glutamate, and N-acetylaspartate (NAA) were found exclusively in the left orbito-frontal cortex of the vulnerable group.
  • Higher glutamate levels were associated with a significantly reduced risk of being classified as vulnerable to driving impairment.

Conclusions:

  • Brain mitochondrial bioenergetics in frontal regions are impaired in OSA patients vulnerable to driving impairment after sleep loss.
  • These findings suggest a potential biomarker (frontal lobe metabolites) for identifying OSA patients at risk when assessing driving fitness.
  • Further validation in larger studies is needed to confirm these results for clinical application.